Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for AUTL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 493.23M
March 31, 2026 527.06M
December 31, 2025 589.07M
September 30, 2025 661.95M
June 30, 2025 720.98M
March 31, 2025 746.34M
December 31, 2024 782.72M
September 30, 2024 827.49M
June 30, 2024 853.62M
March 31, 2024 901.44M
December 31, 2023 375.38M
September 30, 2023 406.10M
June 30, 2023 450.99M
March 31, 2023 459.97M
December 31, 2022 490.27M
Date Value
September 30, 2022 263.83M
June 30, 2022 313.98M
March 31, 2022 363.99M
December 31, 2021 405.56M
September 30, 2021 296.64M
June 30, 2021 330.66M
March 31, 2021 349.75M
December 31, 2020 294.24M
September 30, 2020 317.08M
June 30, 2020 310.55M
March 31, 2020 337.66M
December 31, 2019 303.53M
September 30, 2019 314.64M
June 30, 2019 346.14M
March 31, 2019 264.36M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Bicycle Therapeutics Plc 606.58M
Biodexa Pharmaceuticals Plc --
argenx SE --
Mereo BioPharma Group Plc 34.71M
Evaxion AS 19.38M

Total Assets (Quarterly) Related Metrics